HCA - Dividend announcements

NEW YORK, Dec. 21, 2021 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") announced today preliminary S&P 500® stock buyback, or share repurchases, data for Q3 2021. Historical data on S&P 500 buybacks are available at www.spdji.com/indices/equity/sp-500.  Key Takeaways: Q3 2021 share repurchases were $234.6 billion, increasing 18.0% from Q2 2021's $198.8 billion expenditure and up 130.5% from Q3 2020' $101.8 billion. 309 companies reported buybacks of at least $5 million for the quarter, up from 294 in Q2 2021, and up from 190 in Q3 2020; 371 issues did some buybacks for the quarter, up from 360 in Q2 2020 and up from 290 in Q3 2020. Buybacks remained top heavy with the top 20 issues acc

Revises 2021 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2021. Key first quarter metrics (all percentage changes compare 1Q 2021 to 1Q 2020 unless otherwise noted): Revenues totaled $13.977 billion Net income attributable to HCA Healthcare, Inc. totaled $1.423 billion, or $4.14 per diluted share Adjusted EBITDA totaled $3.052 billion Cash flows from operating activities totaled $1.988 billion Same facility admissions declined 4.2 percent and same facility equivalent admissions declined 6.5 percent "The first quarter is yet another period where the disciplined operating culture and strong executi

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2020. Key fourth quarter metrics (all percentage changes compare 4Q 2020 to 4Q 2019 unless otherwise noted): Revenues totaled $14.293 billion Net income attributable to HCA Healthcare, Inc. totaled $1.426 billion, or $4.13 per diluted share Adjusted EBITDA totaled $3.118 billion Cash flows used in operating activities totaled $3.583 billion (includes the return, or early repayment, of over $6 billion in CARES Act funds) Same facility admissions and same facility equivalent admissions declined 3.4 percent and 7.5 pe